X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-02-12 | ENTA | Luly Jay R. | Pres, CEO | P - Purchase | $5.69 | +45,000 | 846,638 | +6% | +$256,050 | ||||||
2024-12-06 | ENTA | Kieffer Tara Lynn | Chief Product Strategy Officer | S - Sale | $8.06 | -2,283 | 29,305 | -7% | -$18,401 | ||||||
2024-12-06 | ENTA | Luu Brendan | Chief Business Officer | S - Sale | $8.06 | -2,283 | 36,047 | -6% | -$18,401 | ||||||
2024-12-06 | ENTA | Rottinghaus Scott T. | Chief Medical Officer | S - Sale | $8.06 | -866 | 17,918 | -5% | -$6,980 | ||||||
2024-12-06 | ENTA | Or Yat Sun | Chief Scientific Officer | S - Sale | $8.06 | -2,591 | 369,109 | -1% | -$20,883 | ||||||
2024-12-06 | ENTA | Mellett Paul J | Chief Fin., Admin Officer | S - Sale | $8.06 | -2,591 | 91,710 | -3% | -$20,883 | ||||||
2024-12-06 | ENTA | Luly Jay R. | Pres, CEO | S - Sale | $8.06 | -5,142 | 801,638 | -1% | -$41,445 | ||||||
| DM | 2024-07-11 | ENTA | Rottinghaus Scott T. | Chief Medical Officer | S - Sale+OE | $15.97 | -11,945 | 21,717 | -35% | -$190,747 | |||||
2024-06-17 | ENTA | Kieffer Tara Lynn | Chief Product Strategy Officer | S - Sale | $12.33 | -7,266 | 32,341 | -18% | -$89,590 | ||||||
2023-12-13 | ENTA | Vance Terry | Dir | S - Sale | $9.12 | -15,295 | 5,800 | -73% | -$139,490 | ||||||
2023-12-05 | ENTA | Luu Brendan | SVP, Business Dev. | S - Sale | $9.63 | -2,125 | 36,736 | -5% | -$20,464 | ||||||
2023-12-05 | ENTA | Kieffer Tara Lynn | SVP, New Prod. Strat., Dev | S - Sale | $9.63 | -2,125 | 37,260 | -5% | -$20,464 | ||||||
2023-12-05 | ENTA | Gardiner Nathaniel S. | SVP, GC | S - Sale | $9.63 | -2,412 | 104,080 | -2% | -$23,228 | ||||||
2023-12-05 | ENTA | Rottinghaus Scott T. | SVP, CMO | S - Sale | $9.63 | -534 | 26,466 | -2% | -$5,142 | ||||||
2023-12-05 | ENTA | Or Yat Sun | SVP, R, D, CSO | S - Sale | $9.63 | -2,412 | 370,695 | -1% | -$23,228 | ||||||
2023-12-05 | ENTA | Mellett Paul J | SVP, Finance, Admin., CFO | S - Sale | $9.63 | -2,412 | 93,549 | -3% | -$23,228 | ||||||
2023-12-05 | ENTA | Luly Jay R. | Pres, CEO | S - Sale | $9.63 | -7,230 | 806,793 | -1% | -$69,625 | ||||||
| D | 2023-03-15 | ENTA | Mellett Paul J | Treasurer, CFO | S - Sale+OE | $44.43 | -10,440 | 97,556 | -10% | -$463,802 | |||||
| D | 2023-03-15 | ENTA | Or Yat Sun | SVP, CSO | S - Sale+OE | $44.45 | -13,925 | 374,702 | -4% | -$618,960 | |||||
| D | 2023-03-13 | ENTA | Luly Jay R. | Pres, CEO | S - Sale+OE | $45.16 | -27,912 | 819,810 | -3% | -$1,260,628 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |